PODCAST · science
BioTech Nation ... with Dr. Moira Gunn
by Moira Gunn
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
Episodes
-
Improving a Drug for Managing Schizophrenia…Heather Turner, CEO, LB Pharmaceuticals
This week on Biotech Nation, Heather Turner of LB Pharmaceuticals joins to discuss a drug that’s new to the US, but not-so-new to Europe, where it’s already been in use for a couple of years. Intended for managing neuropsychiatric conditions like Schizophrenia, the drug is taken by several…
more -
From Film to Biotech...Toshi Iida, Chairman, FUJIFILM Biotechnologies
When you think of FUJIFILM, you might be picturing rolls of camera film...but it turns out that's not all they've been working on. FUJIFILM Biotechnologies Chairman Toshi Iida joins to share more about how they're innovating in the world of biotech.
-
Reengineering Chemotherapy for Solid Tumors...Lew Bender, Founder, President & CEO, Intensity Therapeutics
What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes…
more -
A New Path Forward for Cell Therapy...Jeff Liter, Founder & CEO, Luminary Therapeutics
This week on BioTech Nation, Jeff Liter of Luminary Therapeutics shares how his team is taking a new approach to advanced cell therapy, in the hopes of making it more accessible and affordable. Rather than formulating a custom treatment using a patient's own cells, they use healthy donor cells…
more -
Paving the Way for Miracle Drugs...Barry Werth, Author, "The Age of Cures"
On this episode of Biotech Nation...the story of how the United States' pharmaceutical industry came to be, and the people behind it all. Barry Werth joins Moira to discuss his new book, “The Age of Cures: How American Scientists Saved Your Life", about a handful of individuals who revolutionized...
-
A Different Approach to Treating Gout...Dr. James Mackay, Co-Founder, CEO, & President, Crystalys Therapeutics
On this episode of BioTech Nation...Dr. James Mackay joins to talk about the progress Crystalys Therapeutics is making in the treatment of gout - a disease that affects more than 13 million people in the United States alone. Dr. Mackay debunks some common misconceptions surrounding the disease…
more -
The Potential of Peptide Drugs...Dr. Karsten Eastman, Co-Founder & CEO, Sethera Therapeutics
You've probably heard of Peptides...but what exactly are they? And how do we know which ones are effective, and safe? Dr. Karsten Eastman, Co-Founder and CEO of Sethera Therapeutics, joins to answer all our questions about Peptides, and to tell us about Sethera's latest efforts to enhance…
more -
Injectable Ice for Chronic Pain? Sameer Sabir, Co-Founder & CEO, Brixton Biosciences
This week on BioTech Nation, Sameer Sabir, CEO of Brixton Biosciences, shares how their breakthrough injectable cold therapy, Neural Ice, could offer lasting relief for osteoarthritis pain. With a drug-free, nerve-targeting approach currently in clinical trials, this innovation may change how we...
-
Healing Hard-to-treat Wounds Faster?? Dr. Ned Swanson, Co-Founder, President & Chief Medical Officer, Polarity Bio
Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early...
-
Stem Cell Therapy for Congenital Heart Defects...Dr. Joshua Hare, Co-Founder & CSO, Longeveron
Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, we hear Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talk about how they are testing the use of stem...
-
Managing Pain While Fighting Cancer...Dr. Lorin Johnson, CSO, Glycyx Therapeutics
This week on BioTech Nation, we explore a new approach to cancer treatment that could help patients manage pain without compromising their care. Dr. Lorin Johnson, CSO of Glycyx Therapeutics explains how a new once-daily pill could help patients manage pain without blocking their treatment.
-
A New Kind of Flu Shot...Dr. Jeff Stein, President & CEO, Cidara Therapeutics
This week on BioTech Nation, Dr. Jeff Stein, President & CEO of Cidara Therapeutics, brings up promising news about a new approach to flu shots.
-
A Not-in-the-Textbooks Discovery for Glioblastoma, Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
On this episode of BioTech Nation, Dr. Will Decker and Jay Hartenbach join Moira to talk about Diakonos Oncology's unique approach to cancer immunotherapy, and how a discovery made over two decades ago started it all. Now, with a new drug entering Phase II human trials for Glioblastoma treatment,...
-
Insulin-Producing Cells...with no Immunosuppressants?? Dr. Steve Harr, Sana Biotechnology
This week on BioTech Nation, Dr. Steve Harr, CEO of Sana Biotechnology, talks about their progress in Type I diabetics, in particular. The New England Journal of Medicine publishes early success with Sana Biotechnology's engineered insulin-producing cells without the need for immunosuppressant...
-
Looking Forward: Biotech in the Balance? Dr. Jeremy Levin, Bioentrepreneur & Former Chair, BIO
On this episode of BioTech Nation...The Biotech landscape is ever-evolving - but where are we headed?? Dr. Jeremy Levin, Physician, Bioentrepreneur, and Former Chair of BIO, joins Moira to talk about the future of Biotech from the front lines of the industry - from understanding the global...
-
How 200 Snake Bites Became an Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax
This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur, Dr. Jake Glanville, Founder, Chair and CEO of Centivax, gives us the insider’s view of this Biotech Breakthrough – from the first...
-
Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remote healthcare technologies, could the future of hospital-like care be as on-demand as a food delivery app?
-
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
On this episode of BioTech Nation: how Syndax Pharmaceuticals got two new drugs approved in the last two years, for the treatment of acute myeloid leukemia and graft vs. host disease in both adults and children. CEO Michael Metzger talks to Moira about Syndax's approach to getting the drugs…
more -
Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
On this episode of BioTech Nation, Dan Schmitt of Actuate Therapeutics talks about a new kind of drug showing positive early results in hard-to-treat cancer - including adult pancreatic cancer, and two pediatric cancers. So, what’s next? Global collaborations, international trials, and efforts…
more -
A Different Way to Treat Parkinson's...Dr. Jonas Hannestad & Dr. Joanne Taylor, Gain Therapeutics
This week on BioTech Nation, Dr. Jonas Hannestad and Dr. Joanne Taylor of Gain Therapeutics join Moira to discuss a different approach to treating Parkinson's. While treatments are typically focused on relieving symptoms, Gain Therapeutics aims to stop progression of the disease itself.
-
Looking Back: A 2007 Interview with Dr. J. Craig Venter
With the recent passing of Dr. J. Craig Venter, biotech scientist and entrepreneur, we look back at Moira and David Ewing Duncan's 2007 interview with Dr. Venter. The occasion for the interview was the publication of his autobiography: "A Life Decoded: My Genome, My Life." Dr. Craig Venter was...
-
50 Years of Genentech...Ashley Magargee, CEO, Genentech
This week on BioTech Nation, we celebrate the 50th anniversary of Genentech, the first biotech company to go public. Moira speaks with CEO Ashley Magargee about the company's journey over the last 50 years, the evolution of biotech, and where they're headed next.
-
The Global Diversity of Human Genetics...Andrew Farnum and Sarah LeBaron von Baeyer, Variant Bio
This week on BioTech Nation, Andrew Farnum and Sarah LeBaron von Baeyer discuss Variant Bio’s unique approach to collecting genetic data - working specifically with indigenous tribes and more isolated populations around the globe. Could compiling this diverse genetic data reveal something about…
more -
Testing New Drugs for Pre-Term Babies... Dr. Marc Salzberg, CEO and Chief Medical Officer, Airway Therapeutics
Dr. Marc Salzberg, CEO & Chief Medical Officer of Airway Therapeutics, talks about what they are doing to help preterm babies. It may all boil down to delivering these babies a single protein as soon as they are born.
-
Now, Near, Next...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's episode of BioTech Nation, Dr. Daniel Kraft discusses the "now-near-next" approach he uses when talking about innovation in healthcare...and beyond. From biotech breakthroughs to AI "agentification", this framework can help us see the bigger picture, and envision the possibilities…
more -
Changing the Future of Cancer Surgery...A 2017 Interview with Dr. Phil Low, Professor & Biotech Entrepreneur
This week on BioTech Nation, we celebrate the life of the late Dr. Phil Low, Purdue University Distinguished Professor of Chemistry and biotech entrepreneur. In this 2017 interview, he describes the development of fluorescence-guided surgery - and why it's a game-changer for cancer treatment.
-
Who is Medically Qualified to Go to Space??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation...want to go to space? Well...it's never too late to follow your dreams, and Tech Nation Health Chief Correspondent Dr. Daniel Kraft joins us to talk about who could medically qualify to climb aboard and rocket into orbit. His answers may surprise you...
-
Big Tech & Healthcare...Dr. Marschall Runge, Author, "The Great Healthcare Disruption"
On this week's BioTech Nation...what could the future of American Healthcare look like? Moira speaks with Dr. Marschall Runge, University of Michigan Medical School Professor, about how Big Tech is quickly redefining the entire healthcare system. His book is, “The Great Healthcare Disruption: Big...
-
Regaining Function? Years Post-Spinal Cord Injury? Dr. Adam Rogers, CEO, NervGen Pharma
On this week’s BioTech Nation, Moira speaks with Dr. Adam Rogers, CEO of NervGen Pharma, about a new treatment that’s showing significant trial results for patients with spinal cord injuries. While typically, patient progress is defined by the early months of recovery after the injury, some trial...
-
A New Approach to Treating ALS...Dr. Arun Swaminathan, CEO, Coya Therapeutics
On this week’s Biotech Nation, Moira speaks with Dr. Arun Swaminathan about an intervention for ALS that Coya Therapeutics is taking into phase two clinical trials. The goal? To stop progression of the disease in its tracks. It could even help in patients with Parkinson’s, Alzheimers, and...
-
The Future of Early Cancer Screening...Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
What if you could routinely screen for early cancer, detecting it while it's easier to treat? Tech Nation Health Chief Correspondent, Dr. Daniel Kraft discusses the latest diagnostics that could allow us to do just that. From blood tests to full-body scans, the future of cancer screening could…
more -
AI in the Exam Room, Dr. Robert Wachter, Author, "A Giant Leap"
On this week’s Biotech Nation, how doctors and hospitals are using AI, and how it could change the practice of medicine. Moira speaks with Dr. Robert Wachter about his book, “A Giant Leap: How AI is Transforming Healthcare and What That Means for Our Future”.
-
ChatGPT...for Healthcare? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
You may already use "Dr. ChatGPT" to answer your medical questions... but now, OpenAI has announced the rollout of ChatGPT Health and OpenAI for Healthcare. Dr. Daniel Kraft has the latest on how each platform will work, and what happens with the health data you share.
-
AI Biology - Chan-Zuckerberg Style? Dr. Shana Kelley, President of Bioengineering, Chan-Zuckerberg Initiative
This week on BioTech Nation, what is AI-Powered Biology? Dr. Shana Kelley, President of Bioengineering and Head of Biohub, Chicago for the Chan-Zuckerberg Initiative, discusses how AI can be used to accelerate research, and what this could mean for the future.
-
A Euphoria-Suppressing Opioid, Ketan Mehta, Founder & CEO, Tris Pharma
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at...
-
You’ve Had Back Pain for 7-10 Years? Neil Klompas, CEO, Augurex
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at...
-
A Fast-Acting Dupixent? Dr. Barry Quart, CEO, Connect Biopharma
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at...
-
A Speedy Intervention for Heart Attacks, Dr. Harry Selker & Dr. Atul Deshpande, Immediate Therapeutics
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at...
-
A New Way to Treat Cancer, Cyriac Roeding & Dr. David Suhy, Co-Founders, Earli
This is the 2026 BioTech Nation "5": Five Companies Ready to Make a Difference. We're highlighting 5 biotech companies with a special release of interviews in time for the 44th Annual J.P. Morgan Healthcare Conference right here in San Francisco. Hear all 5 interviews at...
-
Decoding Diseases of Aging...Dr. Martin Borch Jensen and Dr. Francisco LePort, Gordian Biotechnology
This week on Biotech Nation, Dr. Martin Borch Jensen and Dr. Francisco LePort from Gordian Biotechnology share a bold new approach to fighting diseases of aging before they take hold. Instead of testing one drug at a time, their technology allows scientists to test hundreds of potential…
more -
When Your Immune System Overreacts...Prof. Dr. Niels Riedemann, Co-Founder & CEO, InflaRx
This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung...
-
Renewed Potential: Reviving an ALS Drug...Dr. Ari Azhir, Founder & CEO, Neuvivo
This week on Biotech Nation, Dr. Ari Azhir, Founder and CEO of Neuvivo, shares the incredible journey of an ALS drug that was once abandoned, but is now making its way toward FDA approval. After two failed phase two trials, the drug was left behind until Dr. Azhir and her team discovered a…
more -
Preventing Pressure Injuries: Detecting the Invisible Signs, Martin Burns, CEO Bruin Biometrics
This week on BioTech Nation, Bruin Biometrics CEO Martin Burns talks about a new diagnostic tool being used to detect and prevent potentially fatal bedsores in their earliest stages.
-
Are we moving from Dr. Google to Dr. ChatGPT??? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
For years, we've all turned to Google to self-diagnose every cough, rash, and weird pain. Dr. Daniel Kraft says the shift is happening, from Dr. Google to Dr. ChatGPT.
-
Connecting the Data that Changes Medicine, Dr. Lincoln Nadauld, President & CEO, Culmination Bio
This week on Biotech Nation, Dr. Lincoln Nadauld shares how Culmination Bio is using 9 million preserved tissue samples and decades of patient data to improve how we understand and treat diseases. From discovering patterns in cancer treatments to exploring breakthroughs in heart and autoimmune...
-
Correcting Gene-based Frontotemporal Dementia, Lisa Deschamps, CEO Aviado Bio
What if we could fix the gene that causes dementia? In this episode, Aviado Bio CEO Lisa Deschamps tells us how her team is working to correct the gene driving many cases of frontotemporal dementia.
-
Tuning your own DNA?? Dr. Derek Jantz, Chief Scientific Officer, Tune Therapeutics
What if you could tune your DNA to fix any mistakes? Dr. Derek Jantz from Tune Therapeutics talks about tuning DNA, not just with humans, but stopping the Hepatitis B virus in its tracks.
-
A New Way to Treat Wounds?? Dr. Ned Swanson, Co-Founder, President & Chief Medical Officer, Polarity Bio
Imagine a world where the toughest wounds heal twice as fast, and patients get their lives back sooner than anyone thought possible. Dr. Ned Swanson, the President and Chief Medical Officer of Polarity Bio, tells us about their approach to healing serious, hard-to-treat skin wounds. In early...
-
Treating the Untreatable in Rheumatoid Arthritis! Rob Armstrong, CEO, Artax Biopharma
40% of all rheumatoid arthritis patients do not respond to any of the current drugs. Rob Armstrong, CEO of Artax Biopharma, aims to bring new hope for those patients who've been left without effective treatment options.
-
Treating babies with congenital heart defects... Dr. Joshua Hare, Co-Founder and Chief Scientific Officer, Longeveron
Can you imagine parents expecting a baby, going in for an ultrasound, and finding out that their baby is missing the heart's left ventricle? This week on BioTech Nation, Dr. Joshua Hare, Co-Founder and Chief Scientific Officer of Longeveron, talks about how they are testing the use of stem cells…
more
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for everyone. These interviews are drawn directly from the public radio program, "Tech Nation", which also can be heard in numerous global radio and podcasting venues.
HOSTED BY
Moira Gunn
CATEGORIES
Loading similar podcasts...
Frequently Asked Questions
How many episodes does BioTech Nation ... with Dr. Moira Gunn have?
BioTech Nation ... with Dr. Moira Gunn currently has 188 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is BioTech Nation ... with Dr. Moira Gunn about?
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture...
How often does BioTech Nation ... with Dr. Moira Gunn release new episodes?
BioTech Nation ... with Dr. Moira Gunn publishes regularly with 188 episodes available. Check the episode list for the typical release schedule.
Where can I listen to BioTech Nation ... with Dr. Moira Gunn?
You can listen to BioTech Nation ... with Dr. Moira Gunn on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts BioTech Nation ... with Dr. Moira Gunn?
BioTech Nation ... with Dr. Moira Gunn is created and hosted by Moira Gunn.
URL copied to clipboard!